The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis.

Saved in:
Bibliographic Details
Title: The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis.
Authors: Kamal MA; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Kovalenko P; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Kosloski MP; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Srinivasan K; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Zhang Y; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Rajadhyaksha M; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Lai CH; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Kanamaluru V; Sanofi, Bridgewater, New Jersey, USA., Xu C; Sanofi, Bridgewater, New Jersey, USA., Sun X; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Simpson EL; Oregon Health and Science University, Portland, Oregon, USA., Paller AS; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA., Siegfried EC; Saint Louis University, St. Louis, Missouri, USA.; Cardinal Glennon Children's Hospital, St. Louis, Missouri, USA., Shumel B; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Bansal A; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Al-Huniti N; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Davis JD; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Nov; Vol. 110 (5), pp. 1318-1328. Date of Electronic Publication: 2021 Aug 24.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34270797
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kamal+MA%22">Kamal MA</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Kovalenko+P%22">Kovalenko P</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Kosloski+MP%22">Kosloski MP</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Srinivasan+K%22">Srinivasan K</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Rajadhyaksha+M%22">Rajadhyaksha M</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Lai+CH%22">Lai CH</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Kanamaluru+V%22">Kanamaluru V</searchLink>; Sanofi, Bridgewater, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Xu+C%22">Xu C</searchLink>; Sanofi, Bridgewater, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Sun+X%22">Sun X</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Simpson+EL%22">Simpson EL</searchLink>; Oregon Health and Science University, Portland, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Paller+AS%22">Paller AS</searchLink>; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Siegfried+EC%22">Siegfried EC</searchLink>; Saint Louis University, St. Louis, Missouri, USA.; Cardinal Glennon Children's Hospital, St. Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Shumel+B%22">Shumel B</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Bansal+A%22">Bansal A</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Al-Huniti+N%22">Al-Huniti N</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Davis+JD%22">Davis JD</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2021 Nov; Vol. 110 (5), pp. 1318-1328. <i>Date of Electronic Publication: </i>2021 Aug 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34270797
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cpt.2366
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1318
    Titles:
      – TitleFull: The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kamal MA
      – PersonEntity:
          Name:
            NameFull: Kovalenko P
      – PersonEntity:
          Name:
            NameFull: Kosloski MP
      – PersonEntity:
          Name:
            NameFull: Srinivasan K
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Rajadhyaksha M
      – PersonEntity:
          Name:
            NameFull: Lai CH
      – PersonEntity:
          Name:
            NameFull: Kanamaluru V
      – PersonEntity:
          Name:
            NameFull: Xu C
      – PersonEntity:
          Name:
            NameFull: Sun X
      – PersonEntity:
          Name:
            NameFull: Simpson EL
      – PersonEntity:
          Name:
            NameFull: Paller AS
      – PersonEntity:
          Name:
            NameFull: Siegfried EC
      – PersonEntity:
          Name:
            NameFull: Shumel B
      – PersonEntity:
          Name:
            NameFull: Bansal A
      – PersonEntity:
          Name:
            NameFull: Al-Huniti N
      – PersonEntity:
          Name:
            NameFull: Davis JD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2021 Nov
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1532-6535
          Numbering:
            – Type: volume
              Value: 110
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Clinical pharmacology and therapeutics
              Type: main
ResultId 1